Antitrust in pharmaceutical markets & geographical rules of origin. (2017)
- Record Type:
- Book
- Title:
- Antitrust in pharmaceutical markets & geographical rules of origin. (2017)
- Main Title:
- Antitrust in pharmaceutical markets & geographical rules of origin
- Other Titles:
- Antitrust in pharmaceutical markets and geographical rules of origin
- Further Information:
- Note: Pierre Kobel, Pranvera Këllezi, Bruce Kilpatrick, editors.
- Editors:
- Kobel, Pierre, 1961-
Këllezi, Pranvera
Kilpatrick, Bruce - Other Names:
- International League of Competition Law.
- Contents:
- Preface; Contents; List of Contributors; Abbreviations; Part I: Antitrust in Pharmaceutical Markets; 1: International Report; 1.1 Introduction and Summary; 1.1.1 Scope to Differentiate Pharmaceutical Cases as a Matter of Law; 1.1.2 Enforcement Patterns and Consumer Protection in Pharmaceutical Cases; 1.1.3 Innovation and Competition Nexus; 1.1.4 Public Finance and Other Considerations; 1.2 Summary of Questionnaire Responses; 1.2.1 Legal Differentiation of Pharmaceutical Cases in Competition Law; 1.2.1.1 Differences in Underlying Legal Standards; 1.2.1.2 Market Definition Classification Systems, the SSNIP Test and Other Substitution EvidencePhysician, Pharmacist and Consumer Choice; Insurance and Price Regulation; 1.2.2 Enforcement Patterns, Specialist Bodies and Reviews, and Consumer Protection Interplays; 1.2.2.1 Enforcement Patterns; 1.2.2.2 Public Enforcement and Fines; 1.2.2.3 Private Enforcement; 1.2.2.4 Sector-Specific Measures and Reviews; 1.2.2.5 Sector-Specific Guidelines; 1.2.2.6 Patent Settlement Register; 1.3 Interaction of Competition Law and Consumer Protection Law; 1.3.1 Innovation and Competition Nexus; 1.3.1.1 Scope of the Patent Test 1.3.1.2 Assessment of Settlements1.3.2 The Role of Public Finance and Insurance and the Promotion of Generic Entry; 1.3.2.1 Insurers and Other Protected Bodies; 1.3.2.2 Price Regulation; Mandatory Drug Pricing; Blended Systems; Models Setting Specified Price Adjustments; Reference Pricing; Reference Pricing as a MeaningfulPreface; Contents; List of Contributors; Abbreviations; Part I: Antitrust in Pharmaceutical Markets; 1: International Report; 1.1 Introduction and Summary; 1.1.1 Scope to Differentiate Pharmaceutical Cases as a Matter of Law; 1.1.2 Enforcement Patterns and Consumer Protection in Pharmaceutical Cases; 1.1.3 Innovation and Competition Nexus; 1.1.4 Public Finance and Other Considerations; 1.2 Summary of Questionnaire Responses; 1.2.1 Legal Differentiation of Pharmaceutical Cases in Competition Law; 1.2.1.1 Differences in Underlying Legal Standards; 1.2.1.2 Market Definition Classification Systems, the SSNIP Test and Other Substitution EvidencePhysician, Pharmacist and Consumer Choice; Insurance and Price Regulation; 1.2.2 Enforcement Patterns, Specialist Bodies and Reviews, and Consumer Protection Interplays; 1.2.2.1 Enforcement Patterns; 1.2.2.2 Public Enforcement and Fines; 1.2.2.3 Private Enforcement; 1.2.2.4 Sector-Specific Measures and Reviews; 1.2.2.5 Sector-Specific Guidelines; 1.2.2.6 Patent Settlement Register; 1.3 Interaction of Competition Law and Consumer Protection Law; 1.3.1 Innovation and Competition Nexus; 1.3.1.1 Scope of the Patent Test 1.3.1.2 Assessment of Settlements1.3.2 The Role of Public Finance and Insurance and the Promotion of Generic Entry; 1.3.2.1 Insurers and Other Protected Bodies; 1.3.2.2 Price Regulation; Mandatory Drug Pricing; Blended Systems; Models Setting Specified Price Adjustments; Reference Pricing; Reference Pricing as a Meaningful Excessive Price Cap; Reference Pricing as a Reference Point for Predatory Pricing Cases; Market Interdependency from Blended Pricing (Potential MFN Effect); Information Exchange Concerns; 1.3.2.3 Regulation of Distribution Margins and Monopoly Distribution Parallel Trade Restrictions1.3.2.4 Generic Entry Promotion; Legal Protection of the Substitution of Generics for Branded Drugs; Barriers to Entry from Supply Obligations; Protection of Generic Products from Reputational Denigration; 1.4 Conclusion and Draft Recommendations; 2: Australia; 2.1 The Pharmaceutical Industry and Competition Law; 2.1.1 Legislation; 2.1.2 Cases and Misuses of Market Power; 2.2 Enforcement Mechanisms, Remedies and Consumer Protection; 2.2.1 Enforcement Patterns Regarding Pharmaceutical Competition Law Issues; 2.2.2 Interaction Between Competition and Consumer Laws 2.2.2.1 Unfair Term Legislation2.2.2.2 Unconscionable Conduct; 2.2.2.3 Misleading Conduct; 2.2.3 Sector-Specific Reviews of Competition Law in the Pharmaceutical Sector; 2.2.3.1 Pharmaceutical Patents Review 2012-2013; 2.2.3.2 Competition Policy Review 2014-2015 (Harper Review); 2.2.3.3 Productivity Commission Review of Intellectual Property; 2.2.3.4 Review of Pharmacy Remuneration and Regulation 2015-2017; 2.2.4 Competition Law Guidelines Relevant to the Pharmaceutical Industry; 2.3 Patent Protection and Competition; 2.3.1 Patent Owners and Generic Drugs in Australia … (more)
- Publisher Details:
- Cham, Switzerland : Springer
- Publication Date:
- 2017
- Extent:
- 1 online resource
- Subjects:
- 344.04/233
Law
Drugs -- Administration -- Law and legislation
Pharmacy -- Law and legislation
Antitrust law
Intellectual property
LAW / Administrative Law & Regulatory Practice
Antitrust law
Drugs -- Administration -- Law and legislation
Intellectual property
Pharmacy -- Law and legislation
Medical -- Pharmacology
Law -- International
Law -- Medical Law & Legislation
Business & Economics -- Business Law
Pharmacology
International economic & trade law
International law
Medical & healthcare law
Company, commercial & competition law
Mass media -- Law and legislation
Toxicology
Public health laws
Commercial law
Law -- Media & the Law
Entertainment & media law
Electronic books - Languages:
- English
- ISBNs:
- 9783319558134
3319558137 - Related ISBNs:
- 9783319558127
3319558129 - Notes:
- Note: Includes bibliographical references.
Note: Vendor-supplied metadata. - Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.364944
- Ingest File:
- 01_337.xml